Increased CXCL10 (IP-10) associates with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Belmonte M, Cabrera-Cosme L, Øbro NF, Li J, Grinfeld J, Milek J, Bennett E, Irvine M, Shepherd MS, Cull AH, Boyd G, Riedel LM, Che JLC, Oedekoven CA, Baxter EJ, Green AR, Barlow JL, Kent DG.
Belmonte M, et al. Among authors: green ar.
Exp Hematol. 2024 May 17:104246. doi: 10.1016/j.exphem.2024.104246. Online ahead of print.
Exp Hematol. 2024.
PMID: 38763471
Free article.